Lilly Biotechnology Center in San Diego, Calif. Senior Correspondent On July 2, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results